The guideline aims to support health professionals in making accurate diagnoses and providing effective treatments. More: NICE to form alliance to produce chronic asthma guideline Source: News
read moreThe CMA alleges that Alliance Healthcare bought equal volumes of nitrofurantoin from the companies to discourage competing. More: Advanz, Morningside, Alliance accused of illegal market sharing Source: News
read moreThe trial met its primary efficacy endpoint of a mean change in haemoglobin from baseline averaged over weeks 23-27. More: AZ’ roxadustat successful in late-stage trial Source: News
read moreSwiss CDMO Lonza may be struggling in some areas, but it is continuing an expansion binge for its pharma manufacturing as it leans more heavily on it to drive its growth. More: Lonza expanding ADC production as pharma business thrives
read moreBiogen may face uncertainty in multiple sclerosis, a new rival to its quick-launching SMA blockbuster, and setbacks in its pipeline, but its biosimilars group is zooming ahead. Sales grew 45% in Q2 to $184 million, and that’s with just a
read moreIn its first full quarter under assault from generic Advair, GlaxoSmithKline still managed to grow sales, thanks to its newer respiratory drugs and the fast-growing Shingrix vaccine. Plus, its cancer pipeline—one of GSK’s top hopes for the future—is taking shape.
read more© 1994 - 2026 B.M. Pharmaceuticals